Distinct Pharmacodynamic Complement Biomarker Signatures Define Iptacopan and Pegcetacoplan Treatment in C3 Glomerulopathy

Overview of attention for article published in Kidney International Reports, September 2026

Altmetric Badge

About this Attention Score

High Attention Score compared to outputs of the same age (80th percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter: 6 X users

bluesky: 1 Bluesky user

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 29,394 followers.

RT @KIReports: Distinct #Pharmacodynamic #Complement Biomarker Signatures Define #Iptacopan and #Pegcetacoplan Treatment in #C3 Glomerulopa…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.